CompletedNCT01759355
Hybrid PET/MR in the Therapy of Cervical Cancer
Studying Squamous cell carcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Principal Investigator
- Jorge Oldan, MDUniversity of North Carolina, Chapel Hill
- Intervention
- FDG PET/MR(procedure)
- Enrollment
- 18 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2012 – 2020
Study locations (1)
- University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01759355 on ClinicalTrials.gov